Global MHealth Apps Market Trends and Insights
Smartphone and Wearable Penetration Extends the mHealth Apps Market's Addressable Base
In 2025, global wearable device shipments reached 611.5 million units, a 9.1% increase from the previous year, significantly expanding the user base for mHealth apps. Policy support and diverse price tiers in China drove connected devices into mainstream adoption, especially in high-volume consumer markets. Apple’s approval for its Hypertension Notification Feature in September 2025 highlighted the role of consumer hardware as a regulated screening tool. With wearables capturing more clinically relevant signals, app developers are enhancing monitoring and coaching products, reducing user input effort and increasing engagement. By 2026, 40% of new wearables are expected to feature AI-enabled functions, driving personalization and performance expectations.AI-Enabled Personalization Shifts the Engagement Model From Reminders to Anticipatory Care
A 2025 review of 66 studies showed machine learning algorithms delivered personalized recommendations in 61% of cases and improved medication adherence in trials. The mHealth apps market is under pressure to deliver measurable value beyond reminder-based interactions. AI is also improving provider workflows by enhancing triage and risk prioritization, reducing alert fatigue. Tempus AI launched 'olivia' in January 2025, integrating with over 1,000 health systems and generating AI-driven clinical summaries. This shift towards coordinated care combines records, device data, and predictive analytics, moving personalization from reminders to proactive interventions and workflow optimization.Data Privacy and Cybersecurity Scrutiny Elevate the Cost of Trust
A 2025 audit of 272 Android mHealth apps revealed an average security score of 47 out of 100, with 42.6% using outdated SHA-1 encryption and 42 apps transmitting unencrypted data. Privacy complaints and technical issues were linked to over 553,000 user reviews, highlighting how trust issues can lead to user abandonment. The mHealth apps market faces rising costs for encryption, consent management, and vendor oversight as platforms collect more complex data. Expanding into multiple regions further complicates compliance due to varying data regulations, increasing operating costs and slowing market scalability.Other drivers and restraints analyzed in the detailed report include:
- Reimbursable Digital Therapeutics Pathways Create a Structural Revenue Floor
- EHR-Embedded Digital Prescribing Workflows Convert App Downloads Into Care Pathways
- Low Long-Term Engagement Undermines Clinical Outcome Evidence and Commercial Viability
Segment Analysis
In 2025, Disease and Treatment Management Apps accounted for 54.75% of the mHealth apps market, driven by chronic condition use cases like CGM-linked diabetes management, medication adherence, and remote monitoring tools. Clinically validated products dominate revenue channels such as reimbursement and employer benefits, keeping medically oriented applications ahead of lifestyle offerings as the market expands.Wellness Management Apps are projected to grow at a 16.70% CAGR from 2026 to 2031, fueled by fitness tracking, nutrition support, mental wellness, sleep monitoring, and weight management. This category broadens the market by engaging users earlier in the prevention journey. DexCom launched its G7 15 Day CGM system in 2025 with companion app features, balancing clinical monetization with prevention-led adoption.
In 2025, iOS captured 48.75% of revenue in the mHealth apps market, driven by higher revenue per user, integration with Apple Watch, and strong positioning in North America and Western Europe. The platform excels in premium chronic care and employer-sponsored programs, where users value its seamless ecosystem.
Android is forecast to grow at a 17.45% CAGR from 2026 to 2031, supported by widespread smartphone adoption in South and Southeast Asia. Affordable devices expand the addressable market, particularly in regions with rising demand for scalable mobile health tools, making Android pivotal for market scale.
Complete Report Scope:
- By App Type
- Disease & Treatment Management Apps
- Chronic Disease Management Apps
- Medication Adherence Apps
- Remote Monitoring Apps
- Women's Health & Pregnancy Apps
- Diagnostic & Symptom Checker Apps
- Wellness Management Apps
- Fitness & Exercise Tracking Apps
- Nutrition & Diet Apps
- Mental Wellness & Mindfulness Apps
- Sleep Tracking Apps
- Weight Management Apps
- Other App Types
- Personal Health Record Apps
- Telehealth & Virtual Consultation Apps
- Health Education & Awareness Apps
- Professional Reference & Networking Apps
- Disease & Treatment Management Apps
- By Platform
- Android
- iOS
- Other Platforms
- By Functionality
- Monitoring Services
- Fitness Solutions
- Diagnostic Services
- Treatment Services
- Care Navigation & Engagement
- By End User
- Patients & Consumers
- Healthcare Providers
- Payers & Employers
- Life Sciences & Research Organizations
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
In 2025, North America accounted for 41.61% of the mHealth apps market, maintaining its position as the largest regional contributor. The region benefits from widespread internet access, a high prevalence of chronic diseases, and a reimbursement structure supporting digital therapeutics under the 2025 Medicare Physician Fee Schedule. In the United States, 14.9% of commercially insured patients had telehealth claims in January 2025, with mental health conditions comprising 58.5% of telehealth diagnostic encounters. High payer density and mature EHR adoption further enhance the region's suitability for reimbursable and integrated application models.Europe remained the second-largest region in the mHealth apps market, driven by stringent data governance and device regulations that favor well-capitalized operators. Frameworks like GDPR and the Medical Device Regulation raise compliance standards, creating barriers for smaller vendors. Public payer pathways, such as the NHS App in the UK and Germany's DiGA framework, support sustainable growth by aligning reimbursement with compliance requirements.
Asia-Pacific is projected to grow at a 15.66% CAGR from 2026 to 2031, making it the fastest-growing region in the mHealth apps market. China leads the region, supported by strong adoption of wearable devices, with its wrist-worn device market expected to reach 79.58 million units by 2026. Huawei shipped 25.5 million smartwatches in 2025, reflecting a 21.7% year-over-year increase. India is the fastest-growing country market, driven by digital health policies and payment infrastructure enabling low-cost subscription models. The Middle East and Africa, though smaller in revenue, are on a growth trajectory due to digital health investments in GCC countries and emerging care delivery models.
List of Companies Covered in this Report:
- Abbott Laboratories
- Ada Health GmbH
- AirStrip Technologies, Inc.
- Apple
- Calm.com, Inc.
- Dexcom
- Doximity, Inc.
- Epic Systems
- Garmin
- Google LLC / Fitbit
- Headspace, Inc.
- Koninklijke Philips
- Medisafe, Inc.
- MyFitnessPal, Inc.
- Noom, Inc.
- Omada Health
- Samsung Group
- Teladoc Health
- Veradigm
- Withings S.A.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Ada Health GmbH
- AirStrip Technologies, Inc.
- Apple Inc.
- Calm.com, Inc.
- DexCom, Inc.
- Doximity, Inc.
- Epic Systems Corporation
- Garmin Ltd.
- Google LLC / Fitbit
- Headspace, Inc.
- Koninklijke Philips N.V.
- Medisafe, Inc.
- MyFitnessPal, Inc.
- Noom, Inc.
- Omada Health, Inc.
- Samsung Electronics Co., Ltd.
- Teladoc Health, Inc.
- Veradigm LLC
- Withings S.A.

